Cargando…
Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
Biliary tract cancer (BTC) is a leading cause of cancer-related death, due to the limited benefits of current systematic therapies and the heterogeneity of the tumor itself. High heterogeneity means that the clinical and molecular features vary between different subtypes of BTC, while the underlying...
Autores principales: | Yang, Wenwei, Sun, Yongkun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920611/ https://www.ncbi.nlm.nih.gov/pubmed/33658799 http://dx.doi.org/10.2147/OTT.S297643 |
Ejemplares similares
-
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments
por: Valery, Marine, et al.
Publicado: (2023) -
Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011) -
Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015) -
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
por: Chakrabarti, Sakti, et al.
Publicado: (2020) -
Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023)